Improving access to complex generic medications
Center for Research on Complex Generics
['FUNDING_OTHER'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10894046
This study is all about making it easier for patients to get safe and effective generic medications by working with the FDA and drug companies to improve how these complex drugs are developed.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10894046 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the development of complex generic drugs by collaborating with the FDA and the generic drug industry. The Center for Research on Complex Generics (CRCG) aims to identify and organize activities that promote first cycle approvals of these medications, making them more accessible to patients. Through collaborative research, training, and workshops, the CRCG will work to advance pharmaceutical development science, ensuring that patients benefit from safe and effective generic options. The initiative includes various activities such as webinars, pilot projects, and a Visiting Scientist Program to foster innovation in drug formulation.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients who require complex medications that may currently be limited in generic options.
Not a fit: Patients who are not seeking complex medications or those whose conditions do not require such treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased availability of affordable and effective complex generic medications for patients.
How similar studies have performed: Other research initiatives have shown success in improving generic drug development, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: POLLI, JAMES E — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: POLLI, JAMES E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.